Updates are available Correction dated 2024-01-12

Article History

Received: 9 August 2023

Accepted: 13 September 2023

First Online: 15 October 2023

Change Date: 12 January 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s13555-023-01090-z

Declarations

:

: Dr. Schleicher has been a speaker for Almirall, Celgene, and Pfizer and has served as a Principal Investigator for Abbvie, Amgen, Astra Zeneca, Cara, Dr. Reddy, Encube, Eli Lilly, Exeltis, Foamix, Galderma, Genentech, Highlight, Nektar, NFlection, Novan, Regeneron, and Taro. Dr. Moore has received honoraria or research funds from Almirall, Galderma, Mayne, Ortho Dermatologics, Parexel, and Vyne. Dr. Rafal has served as an investigator for Abbvie, Actavis, Allergan, Amgen, Arcutis, Cassiopea, Celgene, Cutanea Life Sciences, Dermavant, Dermira, Dow, Dr. Reddy's Laboratories, Foamix, Galderma, MC2 Therapeutics, Novan, Pfizer, Sol–Gel Technologies, and Valeant. Dr. Gagné-Henley has received honoraria from AbbVie, Amgen, Bausch Health, Celgene, Galderma, Janssen, Novartis, Valeant, and Xenon. Dr. Johnson has been advisor or speaker for Nielsen, Amgen, Allergan, Regeneron, Sanofi Genzyme, and Candela, and an investigator for Arcutis, Aurigene, Amgen, Regeneron, Galderma, Nielsen, Dermavant, Lilly, Therapeutics, GSK, Aclaris, Foamix, Novartis, Abbvie, Gage, Cassiopea, National Psoriasis Foundation, and University of Pennsylvania. Dr. Dhawan S has served as an investigator for Galderma. Dr. Chavda, Dr. Sforzolini, and Dr. York are employees of Galderma. Dr. Holcomb has been a speaker or advisor for Galderma, Abbvie, Bristol Myers Squibb, Revanesse, Almirall, Evolus, Innocutis, and Ranbaxy and an investigator for Galderma, Abbvie, DermTech, Corevitas, Evols, Aclaris, and Neothetics. Dr. Ablon is an Investigator and speaker for Galderma, Bausch Health, Nutrafol, and Valeant. Dr. Del Rosso J has served as a consultant, investigator, and/or speaker for Ortho Dermatologics, Abbvie, Amgen, Arcutis, Dermavant, EPI Heath, Galderma, Incyte, LEO Pharma, Lilly, MC2 Therapeutics, Pfizer, Sun Pharma, and UCB. Pr Dreno has served as an investigator/consultant for Galderma, Pierre Fabre, La Roche Posay International, Novartis, Bristol-Myers Squibb, and Sun Pharma.

: Ethics approval was obtained for the study conduct. Approval for the US and Canada was provided by wcg IRB for protocol RD.06.SPR.202395 and IRB tracking number 20211170. Approval for France was provided by Comite de protection des personnes Sud Mediterranee, Hopital Sainte Margeurite, Marseille, France Ref CPP 2144, Ref SI 21.04.16.78234, EudraCT 2020-006050-51. All patients and/or guardians provided written informed consent.